Shoshana Zha, MD, PhD

Shoshana (she/her/hers) attended The College of William and Mary for undergraduate degree in Neuroscience/Biochemistry. Her first lab was at The College under Dr. John Griffin studying neural pathways involved in thermoregulation. She then moved to Medical College of Virginia to complete her MD/PhD. Her dissertation was under the advisorship of Dr. Huiping Zhou, studying the mechanisms underlying HIV protease inhibitors induced dyslipidemia. She then moved across the country to Seattle Washington and completed an Internal Medicine Residency at the University of Washington. During this time, she worked in the laboratory of Dr. David Sherman, aiding in the optimization of a novel dihydrofolate reductase inhibitor specific to Mycobacterium tuberculosis. She continued working in Dr. Sherman's laboratory and the ICU for one year prior to joining the Pulmonary/Critical Care Fellowship Program at UCSF in 2017. She joined the laboratory of Dr. Oren Rosenberg, in conjunction with mentorship by Dr. Joel Ernst, in 2019. Her studies focus on unique subsets of mononuclear phagocytes in the lung during Mycobacterium tuberculosis infection.